• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏疾病中的肝微循环障碍:中医药干预

Hepatic microcirculatory disturbance in liver diseases: intervention with traditional Chinese medicine.

作者信息

Liu Pei, Liang Wan-Li, Huang Rui-Ting, Chen Xin-Xing, Zou De-Hua, Kurihara Hiroshi, Li Yi-Fang, Xu You-Hua, Ouyang Shu-Hua, He Rong-Rong

机构信息

State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau SAR, China.

Guangdong Engineering Research Center of Traditional Chinese Medicine & Disease Susceptibility, Guangdong-Hong Kong-Macao Universities Joint Laboratory for the Internationalization of Traditional Chinese Medicine, Guangzhou Key Laboratory of Traditional Chinese Medicine & Disease Susceptibility, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China.

出版信息

Front Pharmacol. 2024 Jul 23;15:1399598. doi: 10.3389/fphar.2024.1399598. eCollection 2024.

DOI:10.3389/fphar.2024.1399598
PMID:39108760
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11300221/
Abstract

The liver, a complex parenchymal organ, possesses a distinctive microcirculatory system crucial for its physiological functions. An intricate interplay exists between hepatic microcirculatory disturbance and the manifestation of pathological features in diverse liver diseases. This review updates the main characteristics of hepatic microcirculatory disturbance, including hepatic sinusoidal capillarization, narrowing of sinusoidal space, portal hypertension, and pathological angiogenesis, as well as their formation mechanisms. It also summarized the detection methods for hepatic microcirculation. Simultaneously, we have also reviewed the characteristics of microcirculatory disturbance in diverse liver diseases such as acute liver failure, hepatic ischemia-reperfusion injury, viral hepatitis, non-alcoholic fatty liver disease, hepatic fibrosis, hepatic cirrhosis, and hepatocellular carcinoma. Finally, this review also summarizes the advancement in hepatic microcirculation attributed to traditional Chinese medicine (TCM) and its active metabolites, providing novel insights into the application of TCM in treating liver diseases.

摘要

肝脏是一个复杂的实质性器官,拥有一个对其生理功能至关重要的独特微循环系统。肝微循环障碍与各种肝脏疾病病理特征的表现之间存在着复杂的相互作用。本综述更新了肝微循环障碍的主要特征,包括肝血窦毛细血管化、窦状隙狭窄、门静脉高压和病理性血管生成,以及它们的形成机制。还总结了肝微循环的检测方法。同时,我们还综述了各种肝脏疾病如急性肝衰竭、肝缺血再灌注损伤、病毒性肝炎、非酒精性脂肪性肝病、肝纤维化、肝硬化和肝细胞癌的微循环障碍特征。最后,本综述还总结了中药及其活性代谢产物在肝微循环方面的进展,为中药在肝病治疗中的应用提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacc/11300221/eee9877685d7/fphar-15-1399598-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacc/11300221/f85dbbee00ef/fphar-15-1399598-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacc/11300221/34180ec00069/fphar-15-1399598-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacc/11300221/eee9877685d7/fphar-15-1399598-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacc/11300221/f85dbbee00ef/fphar-15-1399598-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacc/11300221/34180ec00069/fphar-15-1399598-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacc/11300221/eee9877685d7/fphar-15-1399598-g003.jpg

相似文献

1
Hepatic microcirculatory disturbance in liver diseases: intervention with traditional Chinese medicine.肝脏疾病中的肝微循环障碍:中医药干预
Front Pharmacol. 2024 Jul 23;15:1399598. doi: 10.3389/fphar.2024.1399598. eCollection 2024.
2
Microcirculatory disturbances and cellular changes during progression of hepatic steatosis to liver tumors.在肝脂肪变性发展为肝肿瘤的过程中微循环障碍和细胞变化。
Exp Biol Med (Maywood). 2018 Jan;243(1):1-12. doi: 10.1177/1535370217738730. Epub 2017 Oct 24.
3
Role of microcirculatory derangements in manifestation of portal triad cross-clamping-induced hepatic reperfusion injury.微循环紊乱在门静脉三联征交叉阻断所致肝再灌注损伤表现中的作用。
J Surg Res. 1996 Jan;60(1):49-54. doi: 10.1006/jsre.1996.0009.
4
Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion.肝微循环灌注衰竭是温暖缺血再灌注中肝功能障碍的一个决定因素。
Am J Pathol. 1994 Dec;145(6):1421-31.
5
Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via the MK/integrin signaling pathway.大黄䗪虫丸通过 MK/整合素信号通路减轻肝硬化和肝癌大鼠模型的肝窦毛细血管化。
J Ethnopharmacol. 2023 May 23;308:116191. doi: 10.1016/j.jep.2023.116191. Epub 2023 Jan 31.
6
Microcirculatory disturbance in acute liver injury is triggered by IFNγ-CD40 axis.急性肝损伤中的微循环紊乱由IFNγ-CD40轴触发。
J Inflamm (Lond). 2024 Jun 21;21(1):23. doi: 10.1186/s12950-024-00387-w.
7
Research progress of traditional Chinese medicine in improving hepatic fibrosis based on inhibiting pathological angiogenesis.基于抑制病理性血管生成的中药改善肝纤维化的研究进展
Front Pharmacol. 2023 Dec 12;14:1303012. doi: 10.3389/fphar.2023.1303012. eCollection 2023.
8
Sinusoidal flow block after warm ischemia in rats with diet-induced fatty liver.饮食诱导性脂肪肝大鼠热缺血后的窦性血流阻断
J Surg Res. 1997 Jun;70(1):12-20. doi: 10.1006/jsre.1997.5077.
9
Sinusoidal microcirculatory changes after small-for-size liver transplantation in rats.大鼠小体积肝移植后窦状微循环的变化。
Transpl Int. 2010 Sep;23(9):924-33. doi: 10.1111/j.1432-2277.2010.01058.x. Epub 2010 Feb 19.
10
Carbon monoxide, but not endothelin-1, plays a major role for the hepatic microcirculation in a murine model of early systemic inflammation.在早期全身炎症的小鼠模型中,一氧化碳而非内皮素-1在肝微循环中起主要作用。
Crit Care Med. 2005 Oct;33(10):2323-31. doi: 10.1097/01.ccm.0000182794.42733.71.

引用本文的文献

1
Integrated multi‑omics analysis of liver metabolic dysregulation in ACE2 knockout mice.ACE2基因敲除小鼠肝脏代谢失调的综合多组学分析
Int J Mol Med. 2025 Sep;56(3). doi: 10.3892/ijmm.2025.5575. Epub 2025 Jul 4.
2
Strain- and sex-dependent variability in hepatic microcirculation and liver function in mice.小鼠肝脏微循环和肝功能的应变及性别依赖性变异性。
World J Gastroenterol. 2025 Apr 21;31(15):101058. doi: 10.3748/wjg.v31.i15.101058.

本文引用的文献

1
An international, multicenter, survey-based analysis of practice and management of acute liver failure.一项国际多中心基于调查的急性肝衰竭实践和管理分析。
Liver Transpl. 2024 Dec 1;30(12):1217-1225. doi: 10.1097/LVT.0000000000000402. Epub 2024 May 23.
2
Hepatitis B virus infection among illegal drug users in Enugu State, Nigeria: prevalence, immune status, and related risk factors.尼日利亚埃努古州非法吸毒者中的乙型肝炎病毒感染:流行率、免疫状况和相关危险因素。
BMC Public Health. 2024 May 9;24(1):1203. doi: 10.1186/s12889-024-18675-8.
3
Psychiatric diagnoses are common after liver transplantation and are associated with increased health care utilization and patient financial burden.
肝移植术后常见精神科诊断,且与增加的医疗保健利用和患者经济负担相关。
Liver Transpl. 2024 Nov 1;30(11):1145-1158. doi: 10.1097/LVT.0000000000000390. Epub 2024 May 8.
4
Transjugular intrahepatic portosystemic shunt: A promising therapy for recompensation in cirrhotic patients.经颈静脉肝内门体分流术:肝硬化患者补偿治疗的一种有前途的疗法。
World J Gastroenterol. 2024 Apr 28;30(16):2285-2286. doi: 10.3748/wjg.v30.i16.2285.
5
Lipopolysaccharide modification enhances the inhibitory effect of clodronate liposomes on hepatic fibrosis by depletion of macrophages and hepatic stellate cells.脂多糖修饰增强了氯膦酸脂质体通过耗尽巨噬细胞和肝星状细胞对肝纤维化的抑制作用。
Chem Biol Interact. 2024 May 25;395:111015. doi: 10.1016/j.cbi.2024.111015. Epub 2024 Apr 23.
6
Pathophysiology of Hepatorenal Syndrome.肝肾综合征的病理生理学。
Adv Kidney Dis Health. 2024 Mar;31(2):87-99. doi: 10.1053/j.akdh.2024.01.002.
7
Hybrid Bioactive Hydrogel Promotes Liver Regeneration through the Activation of Kupffer Cells and ECM Remodeling After Partial Hepatectomy.杂交生物活性水凝胶通过部分肝切除术后激活枯否细胞和细胞外基质重塑促进肝脏再生。
Adv Healthc Mater. 2024 Jul;13(17):e2303828. doi: 10.1002/adhm.202303828. Epub 2024 Apr 21.
8
Optimizing nutrition in hepatic cirrhosis: A comprehensive assessment and care approach.优化肝硬化患者的营养:全面评估与护理方法。
World J Gastroenterol. 2024 Mar 14;30(10):1313-1328. doi: 10.3748/wjg.v30.i10.1313.
9
Tofogliflozin Delays Portal Hypertension and Hepatic Fibrosis by Inhibiting Sinusoidal Capillarization in Cirrhotic Rats.托格列净通过抑制肝硬化大鼠窦状隙毛细血管化延迟门静脉高压和肝纤维化。
Cells. 2024 Mar 19;13(6):538. doi: 10.3390/cells13060538.
10
Role of Selenoprotein W in participating in the progression of non-alcoholic fatty liver disease.硒蛋白 W 在参与非酒精性脂肪性肝病进展中的作用。
Redox Biol. 2024 May;71:103114. doi: 10.1016/j.redox.2024.103114. Epub 2024 Mar 5.